IGM Biosciences

0 followers


IGM Biosciences (Nasdaq: IGMS) is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic application... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Fred M. Schwarzer

Collapse
Chris H. Takimoto
Chief Medical Officer
Carrie Brodmerkel
Chief Scientific Officer, IGM Autoimmunity & Inflammation
John Shiver
Chief Strategy Officer, IGM Infectious Diseases
Bruce Keyt
Chief Scientific Officer
Lisa L. Decker
Chief Business Officer
George A. Gauthier
Chief Commercial Officer
Suzette Tauber
Chief Human Resources Officer
Marvin S. Peterson
EVP, Process Development & Manufacturing
Elizabeth Haanes
SVP, Intellectual Property
Angus M. Sinclair
SVP, Immuno-Oncology
Elaine Sapinoso
SVP, Quality
Faraz Siddiqui
SVP, Manufacturing Operations